From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report

Naghavi, Morteza; Falk, Erling; Hecht, Harvey S.; Jamieson, M. J.; Kaul, Sanjay; Berman, Daniel S.; Fayad, Zahi A.; Budoff, Matthew J.; Rumberger, John A.; Naqvi, Tasneem Z.; Shaw, Leslee J.; Færgeman, Ole; Cohn, Jay N.; Bahr, Raymond D.; Köenig, Wolfgang; Demirovic, Jasenka; Arking, Dan E.; Herrera, Victoria L. M.; Badimón, Juan J.; Goldstein, James A.; Rudy, Yoram; Airaksinen, Juhani; Schwartz, Robert S.; Riley, Ward A.; Mendes, Robert A.; Douglas, Pamela S.; Shah, Prediman K.

doi:10.1016/j.amjcard.2006.03.002

Cited by 551 publications

(370 citation statements)

References 108 publications

Supporting

Mentioning

332

Contrasting

Unclassified

Order By: Relevance

“…5 The Society for Heart Attack Prevention and Eradication task force issued a stronger recommendation, suggesting that all asymptomatic men 45 to 75 years of age and women 55 to 75 years of age who do not have very-low-risk characteristics (ie, absence of any traditional cardiovascular risk factors) or a documented history of CVD undergo CACS or CIMT screening for the detection of subclinical atherosclerosis. 83 In an analysis from the Atherosclerosis Risk in Communities study, addition of CIMT and plaque detection via ultrasonography to traditional risk factors improved coronary heart disease risk prediction. 84 In the Multi-Ethnic Study of Atherosclerosis, CACS was a better predictor of CVD than was CIMT.…”

Section: Treatment Additional Cardiovascular Evaluation and Referralmentioning

confidence: 99%

The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease

Nehra

Jackson

Miner

et al. 2012

Mayo Clinic Proceedings

404

333

View full text Add to dashboard Cite

The Princeton Consensus (Expert Panel) Conference is a multispecialty collaborative tradition dedicated to optimizing sexual function and preserving cardiovascular health. The third Princeton Consensus met November 8 to 10, 2010, and had 2 primary objectives. The first objective focused on the evaluation and management of cardiovascular risk in men with erectile dysfunction (ED) and no known cardiovascular disease (CVD), with particular emphasis on identification of men with ED who may require additional cardiologic work-up. The second objective focused on reevaluation and modification of previous recommendations for evaluation of cardiac risk associated with sexual activity in men with known CVD. The Panel's recommendations build on those developed during the first and second Princeton Consensus Conferences, first emphasizing the use of exercise ability and stress testing to ensure that each man's cardiovascular health is consistent with the physical demands of sexual activity before prescribing treatment for ED, and second highlighting the link between ED and CVD, which may be asymptomatic and may benefit from cardiovascular risk reduction. T he Princeton Consensus Conference is a multispecialty collaborative tradition dedicated to optimizing sexual function and preserving cardiovascular health. The first conference convened in June 1999 to develop recommendations for clinical management of sexual dysfunction in men and women with known cardiovascular disease (CVD). This conference also provided a multidisciplinary forum for evaluation of the potential cardiovascular risk posed by sexual activity in atrisk patients. The first Princeton Consensus Conference recommendations 1 included stratification of patients by level of cardiac risk associated with sexual activity based on existing CVD. Those at low risk could initiate or resume sexual activity and be treated for sexual dysfunction. For those at high risk, sexual activity was deferred until the cardiac condition was stabilized. The second Princeton Consensus Conference convened in June 2004 and expanded the recommendations of the first conference to emphasize risk factor evaluation and lifestyle management for all men with erectile dysfunction (ED). 2 The second conference recommendations also incorporated new information on the appropriate use of phosphodiesterase type 5 (PDE5) inhibitors in men with ED and concomitant CVD.The third Princeton Consensus Conference took place November 8 to 10, 2010, in Miami Beach, Florida. The group revisited and updated their 2005 recommendations regarding the cardiovascular risk associated with sexual activity in men with known CVD. 2 In addition, the third conference focused on the predictive value of vasculogenic ED in assigning cardiovascular risk in men of all ages, with the primary objective being development of an approach to cardiovascular risk assessment in younger men with ED and no known CVD. The role of testosterone in erectile function and cardiovascular health and the utility of testosterone replacement...

show abstract

Section: Treatment Additional Cardiovascular Evaluation and Referralmentioning

confidence: 99%

The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease

Nehra

Jackson

Miner

et al. 2012

Mayo Clinic Proceedings

404

333

View full text Add to dashboard Cite

show abstract

“…[40][41][42] This may be helpful as surrogate endpoints for intervention studies, as well as potentially add to global CVD risk assessment and guide treatment decisions. [43][44][45][46][47] Subclinical atherosclerosis is commonly assessed by carotid intima-media thickness (cIMT), coronary artery calcium score (CACS), coronary computed tomography angiography (CCTA) and cardiac magnetic resonance imaging (CMR). [5,[46][47][48][49][50][51][52][53][54][55][56][57][58] In recent years, some groups have started to evaluate these imaging techniques in former preeclampsia patients, as discussed below.…”

Section: Cardiovascular Imagingmentioning

confidence: 99%

Determinants of future cardiovascular health in women with a history of preeclampsia

et al. 2015

View full text Add to dashboard Cite

Please cite this article as: Zoet Gerbrand A, Koster Maria PH, Velthuis Birgitta K, de Groot Christianne JM, Maas Angela HEM, Fauser Bart CJM, Franx Arie, Rijn Bas B.van.Determinants of future cardiovascular health in women with a history of preeclampsia.Maturitas http://dx.doi.org/10.1016/j.maturitas. 2015.07.004 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Keywords:Preeclampsia, cardiovascular disease, risk assessment, screening, prevention Highlights  Female-specific risk factors, among which preeclampsia, may have additional value in cardiovascular screening.  Non-invasive imaging techniques can be helpful to detect early-stage cardiovascular lesions as a sign of subclinical atherosclerotic disease.  Preliminary studies show positive effects of short-term lifestyle interventions following preeclampsia.  There is a need for clinical practice guidelines that provide long-term strategies in women after preeclampsia in pregnancy to improve cardiovascular health. AbstractWomen who develop preeclampsia have an increased risk of cardiovascular disease (CVD) later in life.However, current guidelines on cardiovascular risk assessment and prevention are unclear on how and when to screen these women postpartum, and about the role of a positive history of preeclampsia in later-life CVD risk management. The aim of this review is to discuss the present knowledge on commonly used cardiovascular screening modalities available to women with a history of preeclampsia, and to discuss recent developments in early detection of CVD using cardiovascular imaging.Furthermore, we explore how female-specific risk factors may have additional value in cardiovascular screening, in particular in relatively young women, although their implementation in clinical practice is challenged by inconsistent results and lack of long-term outcome data. Non-invasive imaging techniques, e.g. coronary artery intima-media thickness (CIMT), can be helpful to detect subclinical atherosclerotic disease, and coronary artery calcium scoring (CACS) has shown to be effective in early detection of cardiovascular damage. However, whilst more short-term and long-term follow-up studies are becoming available, few studies have investigated women with a history of preeclampsia in the fourth and fifth decade of life, when early signs of premature CVD are most likely to become apparent.Further studies are needed to inform new and improved clinical practice guidelines, and provide longterm strategies to effectively prevent CVD, specifically targeted at women with a history of preeclampsia. Additionally, evaluation of feasibility, cost-effectiveness ...

show abstract

“…If using the 4.09% as borderline of significant change in the rate, the time of follow up can be shortened to 3 years in this study cohort. The guidelines of CAC scan recommended five-year interval of reassessment for those with a positive test result of atherosclerosis, and every 5-10 years for those with a negative test result [110]. Based on the result deduced from this study, it may be reasonable to suggest using the same time interval, and the same CACs image to monitor both osteoporosis and atherosclerosis in the general population.…”

Section: Follow-up Time Using the Qctmentioning

confidence: 79%

Application of quantitative computed tomography for assessment of trabecular bone mineral density, microarchitecture and mechanical property

et al. 2016

Self Cite

View full text Add to dashboard Cite

a b s t r a c t a r t i c l e i n f oOsteoporosis is a common metabolic bone disease, causing increased skeletal fragility characterized by a low bone mass and trabecular microarchitectural deterioration. Assessment of the bone mineral density (BMD) is the primary determinant of skeletal fragility. Computed tomography (CT)-based trabecular microarchitectural and mechanical assessments are important methods to evaluate the skeletal strength. In this review, we focus the feasibility of QCT BMD measurement using a calibration phantom or phantomless. The application of QCT could extend the bone mineral density assessment to all patients who underwent a heart, lung, whole-body, and as well as all routine clinical implications of CT scan.

show abstract

From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report

Cited by 551 publications

References 108 publications

The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease

The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease

Determinants of future cardiovascular health in women with a history of preeclampsia

Application of quantitative computed tomography for assessment of trabecular bone mineral density, microarchitecture and mechanical property

Contact Info

Product

Resources

About